The following are the top 5 new innovations in health care technology, some of which aided in the early lung cancer diagnosis of Amos B, a 58-year-old man who had been coughing up blood for 2 months. Amos was also experiencing loss of appetite, hoarseness, wheezing, and shortness of breath; he had smoked 2 packs of non-filtered cigarettes daily since he was 15 years old.
Amos’ early lung cancer was diagnosed using artificial intelligence for the analysis of his lung CT and of lung biopsy samples. He received early treatment and recovered completely.
#1 – Artificial Intelligence for Use in the Pathological Diagnosis of Lung Cancer
Artificial intelligence (AI) refers to the performance of tasks by computers that normally would require the input of human intelligence.
Using AI, specialized pathology computer programs are able to diagnose lung cancer based on the recognition of abnormalities found on slides of pathological specimens of lung tissue.
To accomplish this, a computer program was programmed to read hundreds of pathological slides of lung tissue and recognize various forms of lung cancer with an accuracy rate even higher than that of pathologists.
#2 – 3D Printing for Use in Total Knee Replacements
3D printers, which were first developed in 1983, make 3-dimensional objects by laying down successive layers of material following a computer-aided design (CAD).
This specialized software uses the specific measurements of CT scans of the knee, hip, and ankle to make an exact 3D model of a patient’s knee.
When a knee replacement is produced by 3D printing, the layers of the knee replacement consist of ABS plastic, resin, stainless steel, gold, silver, titanium, ceramic, and gypsum.
This process has been used in over 100,000 complete knee replacements during 2019.
3D-printed knee replacement results in shorter hospital stays, decreased recovery times, decreased post-operative pain, increased post-operative range of motion, and a better overall custom fit.
#3 – Shravya Shetty: Artificial Intelligence Used to Diagnose Lung Cancer by Chest CT
Shravya Shetty, the head researcher of a Google Health Team, has developed an artificial intelligence algorithm to accurately diagnose lung cancer by analyzing chest CT scans.
The AI algorithm follows a set of commands (algorithms) to analyze the chest CT and even “learns” as it reviews CT scans.
After being trained with 45,000 lung cancer patients’ chest CT scans fed into an AI program, the AI program picked up 5% more cases of lung cancer then a team of 6 board-certified radiologists.
It also had 11% fewer false positive readings.
#4 – Semma Therapeutics Implantable Device for Insulin Delivery
Semma Therapeutics, recently acquired by Vertex Pharmaceuticals, is in the process of developing an implantable device for type 1 diabetes (which occurs due to an autoimmune response that attacks the insulin-producing beta cells of the pancreas).
This implantable device contains a supply of pancreatic islet cells derived from high-quality human pluripotent stem cells.
These stem-cell derived pancreatic cells have been found to produce almost normal levels of insulin and successfully lower blood sugar levels.
The insulin is released through the membrane of the device, which is permeable to insulin and glucose but not to immune cells.
This keeps immune cells out of the device, thus avoiding immune reactions such as organ rejection.
#5 – D’OXYVA Deoxyhemoglobin Peripheral Vasodilator
D’OXYVA is an innovative, painless, non-invasive, deoxyhemoglobin vasodilator application that works by applying a transdermal vapor of CO2 and water through the skin of the thumb over a 5-minute period.
The CO2 then travels to the microcirculation system (smallest blood vessels in the body: arterioles, venules, and capillaries), where it stimulates vasodilation.
This vasodilation of the microcirculation system increases the amount of oxygen and nutrients delivered to the tissues, which results in various healing effects.
D’OXYVA, which is produced by Circularity Healthcare, has been used with great application success in non-healing diabetic foot ulcers, chronic wounds, chronic pain, depression, poor athletic performance, cardiovascular rehabilitation, migraine headaches, diabetic neuropathy, varicose and spider veins, and other conditions.
HOW D’OXYVA CAN HELP?
D’OXYVA is the only fully noninvasive, completely painless transdermal (over-the-skin) microcirculatory solution that has been validated to significantly improve microcirculation.
The improvement of microcirculation, i.e., blood flow to the smallest blood vessels, benefits one’s health, immune system and overall sense of well-being in a variety of ways.